4.7 Article

Acute detachment of hexokinase II from mitochondria modestly increases oxygen consumption of the intact mouse heart

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 72, Issue -, Pages 66-74

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2017.04.008

Keywords

Oxygen consumption; Cardiac metabolism; Hexokinase II; Stable isotopes

Funding

  1. Dutch Heart Foundation [NHS2010B011]

Ask authors/readers for more resources

Objective. Cardiac hexokinase II (HKII) can translocate between cytosol and mitochondria and change its cellular expression with pathologies such as ischemia-reperfusion, diabetes and heart failure. The cardiac metabolic consequences of these changes are unknown. Here we measured energy substrate utilization in cytosol and mitochondria using stabile isotopes and oxygen consumption of the intact perfused heart for 1) an acute decrease in mitochondrial HKII (mtHKII), and 2) a chronic decrease in total cellular HKII. Methods/results. We first examined effects of 200 nM TAT (Trans-Activator of Transcription)-HKII peptide treatment, which was previously shown to acutely decrease mtHKII by similar to 30%. In Langendorff-perfused hearts TAT-HKII resulted in a modest, but significant, increased oxygen consumption, while cardiac performance was unchanged. At the metabolic level, there was a nonsignificant (p = 0.076) similar to 40% decrease in glucose contribution to pyruvate and lactate formation through glycolysis and to mitochondrial citrate synthase flux (6.6 +/- 1.1 vs. 11.2 +/- 2.2%), and an 35% increase in tissue pyruvate (27 2 vs, 20 2 pmol/mg; p = 0.033). Secondly, we compared WT and HKII+/- hearts (50% chronic decrease in total HKII). RNA sequencing revealed no differential gene expression between WT and HKII+/- hearts indicating an absence of metabolic reprogramming at the transcriptional level. Langendorff-perfused hearts showed no significant differences in glycolysis (0.34 +/- 0.03 mu mol/min), glucose contribution to citrate synthase flux (35 +/- 2.3%), palmitate contribution to citrate synthase flux (20 +/- 1.1%), oxygen consumption or mechanical performance between WT and HKII+/- hearts. Conclusions. These results indicate that acute albeit not chronic changes in mitochondrial HKII modestly affect cardiac oxygen consumption and energy substrate metabolism. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-Arat model

Constance Delwarde, Claire Toquet, Pascal Aumond, Amir Hossein Kayvanjoo, Adrien Foucal, Benjamin Le Vely, Manon Baudic, Benjamin Lauzier, Stephanie Blandin, Joelle Veziers, Perrine Paul-Gilloteaux, Simon Lecointe, Estelle Baron, Ilaria Massaiu, Paolo Poggio, Severine Remy, Ignacio Anegon, Herve Le Marec, Laurent Monassier, Jean Jacques Schott, Elvira Mass, Julien Barc, Thierry Le Tourneau, Jean Merot, Romain Capoulade

Summary: This study aimed to identify the main pathophysiological pathways involved in degenerative mitral valve dystrophy (MVD) through multimodality imaging and transcriptomic analysis of a unique knock-in rat model. The study found that extracellular matrix organization, epithelial cell migration, response to mechanical stress, and immune cell contribution are the main signaling pathways leading to MVD.

CARDIOVASCULAR RESEARCH (2023)

Article Genetics & Heredity

A novel deleterious ETFA promoter variant causative of multiple acyl-CoA dehydrogenase deficiency

Pankaj Prasun, Anthony Evans, Emalyn Cork, Sander M. Houten, Bryn D. Webb

Summary: A novel homozygous promoter variant in the ETFA gene was identified in a patient with multiple acyl-CoA dehydrogenase deficiency (MADD), leading to decreased expression of ETFA protein. This finding may contribute to the molecular diagnosis in MADD patients with characteristic biochemical profile but apparently normal molecular studies.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Medicine, General & Internal

Evaluation of Health Care Providers Satisfaction with the Implementation of a Transitional Pain Service

Manouk Admiraal, Jeroen Hermanides, Markus W. Hollmann, Henning Hermanns

Summary: Chronic postsurgical pain affects 10% of patients after surgery. Transitional Pain Service (TPS), a multidisciplinary patient-tailored intervention, has been developed and implemented to improve perioperative pain management and prevent chronic postsurgical pain. A satisfaction survey was conducted among healthcare providers to analyze their satisfaction and learn from their experiences on TPS implementation. The survey showed that 81.0% of staff members strongly felt that patient care had improved with the introduction of TPS, and 86.8% wanted to continue using TPS in the future. Overall, healthcare provider satisfaction improved after the implementation of TPS in our hospital.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Endocrinology & Metabolism

Hyperglycaemic hyperosmolar state and cerebral thrombophlebitis in paediatrics: A case report

Maud Injeyan, Sabine Baron, Benjamin Lauzier, Benedicte Gaillard-Le Roux, Manon Denis

Summary: This article presents a case of a 21-month-old boy with consciousness disorders who was diagnosed with type 1 diabetes with hyperosmolar state and developed cerebral venous thrombosis. It highlights the importance of early recognition and appropriate treatment of hyperglycaemic hyperosmolar state, as well as gradual reduction of blood osmolarity to prevent cerebral complications.

ENDOCRINOLOGY DIABETES & METABOLISM (2023)

Review Biochemistry & Molecular Biology

The biochemistry and physiology of long-chain dicarboxylic acid metabolism

Pablo Ranea-Robles, Sander M. Houten

Summary: Mitochondrial β-oxidation is the primary pathway for fatty acid oxidation, but alternative oxidative metabolism exists. One of these pathways is fatty acid β-oxidation, which forms dicarboxylic acids as products. These dicarboxylic acids are metabolized through peroxisomal β-oxidation, providing an alternative pathway that may counteract the toxic effects of fatty acid accumulation. This review summarizes the biochemical mechanism of dicarboxylic acid formation and degradation through β- and α-oxidation, respectively, and discusses their role in different (patho)physiological states, with a focus on the intermediates and products generated through peroxisomal β-oxidation. Overall, this review aims to enhance the understanding of dicarboxylic acid metabolism and inspire future research.

BIOCHEMICAL JOURNAL (2023)

Article Anesthesiology

International Survey on Perioperative Management of Patients With Infective Endocarditis

Jennifer S. Breel, Susanne Eberl, Benedikt Preckel, Ragnar Huhn, Markus W. Hollmann, Steffen Rex, Henning Hermanns

Summary: This international survey evaluated the current practice among cardiac anesthesiologists in the perioperative management of patients with infective endocarditis and their role in multidisciplinary decision-making. Heterogeneity in treatment approaches was identified, indicating relevant knowledge gaps that should encourage further clinical research to optimize treatment and postoperative outcomes in this specific population.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2023)

Article Endocrinology & Metabolism

Acyl-CoA dehydrogenase substrate promiscuity: Challenges and opportunities for development of substrate reduction therapy in disorders of valine and isoleucine metabolism

Sander M. M. Houten, Tetyana Dodatko, William Dwyer, Sara Violante, Hongjie Chen, Brandon Stauffer, Robert J. J. DeVita, Frederic M. Vaz, Justin R. R. Cross, Chunli Yu, Joao Leandro

Summary: This study suggests that inhibition of SBCAD enzyme can reduce the accumulation of toxic metabolic intermediates in disorders of valine and isoleucine metabolism, providing a new approach for treating related diseases.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Article Multidisciplinary Sciences

Patients with infective endocarditis undergoing cardiac surgery have distinct ROTEM profiles and more bleeding complications compared to patients without infective endocarditis

Jennifer S. Breel, Agnes G. C. L. Wensing, Susanne Eberl, Benedikt Preckel, Patrick Schober, Marcella C. A. Muller, Robert J. M. Klautz, Markus W. Hollmann, Henning Hermanns

Summary: This study aims to delineate the specific coagulation patterns and their clinical consequence in patients undergoing cardiac surgery due to infective endocarditis. The findings show significantly altered coagulation profiles in patients with infective endocarditis, with concomitant hyper- and hypocoagulability. The incidence of bleeding complications and transfusion requirements were also increased in patients with endocarditis.

PLOS ONE (2023)

Review Medicine, General & Internal

Peripheral Regional Anesthesia Using Local Anesthetics: Old Wine in New Bottles?

Lukas Gasteiger, Lukas Kirchmair, Elisabeth Hoerner, Ottokar Stundner, Markus W. Hollmann

Summary: During the past decade, efforts have been made to prolong the analgesic effect of regional anesthesia. The development of extended-release formulations and enhanced selectivity for nociceptive sensory neurons has contributed to the advancement of pain medications. Liposomal bupivacaine is currently the most popular controlled drug delivery system, but its duration of action and cost have limited its widespread use. Continuous techniques and the addition of established substances have been explored to provide prolonged analgesia.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cell Biology

Pharmacological Cardioprotection against Ischemia Reperfusion Injury-The Search for a Clinical Effective Therapy

Qian Wang, Coert J. Zuurbier, Ragnar Huhn, Carolin Torregroza, Markus W. Hollmann, Benedikt Preckel, Charissa E. van den Brom, Nina C. Weber

Summary: Pharmacological conditioning aims to protect the heart from myocardial ischemia-reperfusion injury. This review updates the recent developments in pharmacological conditioning and summarizes the clinical evidence of these strategies in the perioperative setting. It discusses the cellular processes during ischemia and reperfusion that contribute to acute injury and explores promising interventions targeting these processes.

CELLS (2023)

Review Cell Biology

Spontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives

Angelique Blangy-Letheule, Amandine Vergnaud, Thomas Dupas, Bertrand Rozec, Benjamin Lauzier, Aurelia A. Leroux

Summary: Sepsis is a life-threatening disease caused by an uncontrolled immune response to infection. Due to a lack of predictive biomarkers and pertinent models, early diagnosis and effective treatment are challenging. Experimental models, mostly conducted on mice, have been used to understand the pathophysiology of sepsis and identify potential biomarkers or targets. However, results from these models are difficult to translate to humans. Horses, which naturally develop sepsis, may offer a promising spontaneous model for sepsis research with implications for both human and veterinary medicine.

CELLS (2023)

Article Biochemistry & Molecular Biology

Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table

Feiko J. M. de Jong, Thijs T. Wingelaar, Paul Brinkman, Pieter-Jan A. M. van Ooij, Anke H. van der Zee, Markus W. Hollmann, Rob A. van Hulst

Summary: The study assessed whether VOCs in exhaled breath after COMEX-30 treatment are early markers of hyperoxic stress and/or POT. Results showed that the identified VOCs are associated with inflammatory responses or pulmonary diseases and most subjects reported pulmonary symptoms reflecting early-stage POT. Therefore, these VOCs are likely markers of POT, not just indicators of hyperbaric hyperoxic exposure.

METABOLITES (2023)

Letter Oncology

Painfully Absent

Suzanne Broens, Frederique H. van Duijnhoven, Markus W. Hollmann, Sabrine N. T. Hemmes

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Epidemiology, Ventilation Management and Outcomes of COPD Patients Receiving Invasive Ventilation for COVID-19-Insights from PRoVENT-COVID

Athiwat Tripipitsiriwat, Orawan Suppapueng, David M. P. van Meenen, Frederique Paulus, Markus W. Hollmann, Chaisith Sivakorn, Marcus J. Schultz, PRoVENT COVID Investigators

Summary: This study found that patients with chronic obstructive pulmonary disease (COPD) have a higher mortality rate in COVID-19 and higher 28-day mortality compared to non-COPD patients. The ventilation management and the use of prone positioning differed slightly between COPD and non-COPD patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

A Rat Model of Clinically Relevant Extracorporeal Circulation Develops Early Organ Dysfunctions

Antoine Persello, Fouzia Souab, Thomas Dupas, Virginie Aillerie, Edith Bigot, Manon Denis, Angelique Erraud, Thomas Pele, Angelique Blangy-Letheule, Pierre Miniou, Philippe Guedat, Michel De Waard, Emmanuelle Abgueguen, Bertrand Rozec, Benjamin Lauzier

Summary: This study aimed to develop a rat model of extracorporeal circulation (ECC) and establish its clinical relevance. The results demonstrated that the rats exhibited hypotension, hyperlactatemia, and behavioral alterations after ECC, similar to human patients. Blood biomarkers and transcriptomic analysis also showed similarities in the ECC response between humans and rats. Therefore, this new rat model appears to be a cost-effective preclinical model of human ECC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Emilie Steinbach, Davide Masi, Agnes Ribeiro, Patricia Serradas, Tiphaine Le Roy, Karine Clement

Summary: The study of the gut microbiome is crucial for understanding and treating metabolic diseases. While research on the fecal microbiome has provided valuable insights, relying solely on this may not be enough to draw comprehensive conclusions. The microbiome in the proximal part of the small intestine may play a significant role in metabolic regulation, but further exploration is needed due to limited accessibility.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4

Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar, Giovanni Nigita, Lalit Sehgal, Michael A. Freitas, Philip N. Tsichlis

Summary: This study reveals the important role of KDM2B in triple-negative breast cancer (TNBC). KDM2B affects cellular resistance to oxidative stress by regulating a network of genes and metabolic enzymes, in collaboration with ATF4 and MYC. Additionally, high expression of KDM2B is associated with poor prognosis in patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Statin therapy in individuals with intermediate cardiovascular risk

Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee

Summary: This study aimed to investigate the optimal LDL-C level after statin therapy in individuals with intermediate cardiovascular risk. The results showed that achieving LDL-C levels <120 mg/dL after statin therapy could lower the event risk.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Ze Chen, Li -Ping Xia, Lang Shen, Dan Xu, Yu Guo, Hui Wang

Summary: Accumulating evidence suggests that NAFLD has an intrauterine origin, with adverse prenatal environments and glucocorticoid exposure playing a crucial role in the developmental programming of fetal hepatic lipid metabolism. The offspring's glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis is programmed in utero, leading to postnatal catch-up growth and disrupted glucose and lipid metabolism, increasing susceptibility to NAFLD. Mismatch between intrauterine and postnatal environments can further disturb the programmed endocrine axes and accelerate the onset of NAFLD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease

Fuwen Zuo, Youzhao Wang, Xinlei Xu, Ruihao Ding, Wei Tang, Yu Sun, Xiaojie Wang, Yan Zhang, Jichao Wu, Yusheng Xie, Min Liu, Ziying Wang, Fan Yi

Summary: This study investigates the role of CCDC92 in the pathogenesis of diabetic kidney disease (DKD). The expression of CCDC92 was found to increase in kidney biopsies from patients with DKD and was correlated with glomerular lipid accumulation. Animal studies further confirmed the induction of CCDC92 in the kidney, particularly in podocytes, and the podocyte-specific deletion of Ccdc92 ameliorated podocyte injury and lipid deposition. CCDC92 was shown to promote podocyte lipotoxicity through ABCA1 signaling-mediated lipid homeostasis. Therefore, CCDC92 may serve as a potential biomarker of podocyte injury in DKD and targeting CCDC92 could be an innovative therapeutic strategy for DKD patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Brown adipose tissue-derived metabolites and their role in regulating metabolism

Khanyisani Ziqubu, Phiwayinkosi Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje

Summary: The discovery and revival of brown adipose tissue (BAT) in adult humans have opened up new possibilities for treating obesity and metabolic diseases. BAT not only plays a role in generating heat, but also secretes signaling molecules known as batokines, which regulate overall metabolism. This review highlights the importance of BAT-derived metabolites in controlling thermogenesis, substrate metabolism, and other biological processes, as well as their potential to alleviate obesity and related metabolic complications.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)